Single 270μgkg-1 -dose rFVIIa vs. standard 90μgkg-1 -dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: A randomized comparison

Haemophilia

Volumn 14, Issue 2, 2008, Pages 287-294

  Young, G ^a   Shafer, F E ^b   Rojas, P ^c   Seremetis, S ^d  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^c NOVO NORDISK INC   (United States)

^d NOVO NORDISK A S   (Denmark)

Author keywords

Bleeding disorder; FEIBA; Haemophilia; NovoSeven; Recombinant FVIIa

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 7 INHIBITOR; BLOOD CLOTTING INHIBITOR; MORPHINE; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7A; HEMOSTATIC AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ABNORMAL LABORATORY RESULT; ADOLESCENT; ADULT; ALGORITHM; ARTHRALGIA; ARTICLE; BACKACHE; BLEEDING; BOLUS INJECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE SEQUENCE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HEMARTHROSIS; HEMOPHILIA; HOME CARE; HUMAN; INFECTION; MALE; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY ARREST; SINGLE DRUG DOSE; SORE THROAT; THROMBOSIS; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG SELF ADMINISTRATION; HEMOPHILIA A; INFANT; MIDDLE AGED; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FACTOR VIIA; HEMARTHROSIS; HEMOPHILIA A; HEMOSTATICS; HUMANS; INFANT; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 40349085780     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01601.x     Document Type: Article

References (18)